Breast cancer risk assessment in patients seen in a gynecologic oncology clinic

International Journal of Gynecological Cancer

Volumn 12, Issue 4, 2002, Pages 389-393

  Miller, B E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGE; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; FEMALE; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; OVARY CANCER; PRIORITY JOURNAL; RISK ASSESSMENT; UTERINE CERVIX CANCER; UTERUS CANCER; VULVA CANCER;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENITAL NEOPLASMS, FEMALE; GYNECOLOGY; HUMANS; MASS SCREENING; MEDICAL ONCOLOGY; MIDDLE AGED; NORTH CAROLINA; RISK ASSESSMENT; URBAN HEALTH SERVICES; WOMEN'S HEALTH SERVICES;

EID: 0036327206     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2002.01112.x     Document Type: Article

References (17)

1. Projecting individualized probabilities of developing breast cancer for white female who are being examined annually
2. NSABP Breast cancer prevention trial risk assessment program, Version 2
3. Validation studies for models projecting the risk of invasive and total breast cancer incidence
4. Validation of a breast cancer risk assessment model in women with a positive family history
5. Validation of the Gail et al. model for predicting individual breast cancer risk
6. Epidemiology and biostatistics program of the National Cancer Institute
7. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
8. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer
9. National surgical adjuvant breast and bowel project breast cancer prevention trial: A reflective commentary
10. Perceptions of breast cancer risk and screening effectiveness in women younger than 50 years of age
11. Breast cancer assessment in indigent women at a public hospital
12. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/Progestin Replacement Study
13. Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1 Study
14. Decision analysis of tamoxifen for the prevention of invasive breast cancer
15. American Society of Clinical Oncology Technical Assessment on Breast Cancer Risk Reduction Strategies: Tamoxifen and raloxifene
16. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention
17. Risk/benefit assessment of tamoxifen to prevent breast cancer-still a work in progress?